Obesity is an established risk factor for gastrointestinal cancers. Interventions that reduce the burden of obesity at both the societal and individual level and targeted interventions among those at higher risk of cancer should be developed, supported by advances in understanding of the biology that underpins the obesity–cancer link.
This is a preview of subscription content, log in via an institution to check access.
References
Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. https://doi.org/10.3322/caac.21492 (2018).
Lauby-Secetan, B. et al. Body fatness and cancer – viewpoint of the IARC working group. N. Engl. J. Med. 375, 794–798 (2016).
Pearson-Stuttard, J. et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 6, e6–e15 (2018).
NCD Risk Factor Collaboration. Worldwide trends in body mass index from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents and adults. Lancet 390, 2627–2642 (2017).
Murphy, N., Jenab, M. & Gunter, M. J. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-018-0038-1 (2018).
Ulrich, C. M. et al. Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-018-0053-2 (2018).
Stefan, N. et al. Metabolically healthy obesity: epidemiology, mechanisms and clinical implications. Lancet Diabetes Endocrinol. 1, 152–162 (2013).
Samson, S. L. & Garber, A. J. Metabolic syndrome. Endocrinol. Metab. Clin. North Am. 43, 1–23 (2014).
Murphy, N. et al. Nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLOS Med. 13, e1001988 (2016).
Kabat, G. C. et al. Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women. Int. J. Cancer 143, 543–551 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gunter, M.J., Riboli, E. Obesity and gastrointestinal cancers — where do we go from here?. Nat Rev Gastroenterol Hepatol 15, 651–652 (2018). https://doi.org/10.1038/s41575-018-0073-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-018-0073-y
- Springer Nature Limited